Milestone achieved: FDA approves nivolumab in combination with cisplatin and gemcitabine for metastatic urothelial carcinoma
Ann Med Surg (Lond)
.
2024 Sep 25;86(11):6389-6392.
doi: 10.1097/MS9.0000000000002601.
eCollection 2024 Nov.
Authors
Nawal Khaliq
1
,
Maryam Sohail
2
,
Shanzay Younas
3
,
Maryam Ishaq
4
,
Aymar Akilimali
5
Affiliations
1
Dow University of Health Sciences, Karachi, Pakistan.
2
D.G. Khan Medical College, Dera Ghazi Khan, Pakistan.
3
Punjab Medical College, Faisalabad Medical University, Faisalabad, Pakistan.
4
Khyber Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan.
5
Department of Research, Medical Research Circle (MedReC), Goma, Democratic Republic of Congo.
PMID:
39525780
PMCID:
PMC11543197
DOI:
10.1097/MS9.0000000000002601
No abstract available
Publication types
Editorial